The future of diabetes management is now!
We live in extraordinary times in diabetes management. Times of technological innovation that make us dream of a not-so-distant future where the risks of type 1 diabetes are minimised and not an impediment for having a healthy baby and a safe pregnancy.
You, as a healthcare professional, are a lead character in re-writing the story for many soon-to-be parents!
Redefining Type 1 Diabetes Care in Pregnancy
CamAPS FX is the only hybrid closed-loop app approved for pregnancy, enabling glucose targets as low as 4.4 mmol/L (80 mg/dL). The landmark AiDAPT study showed a +10.5 % improvement in time in the pregnancy-specific target range, fewer complications, and lasting benefits for mothers and babies.
Your guide to help you manage type 1 diabetes & pregnancy when using myLoop
Deep dive into how to counsel and care for women managing their type 1 diabetes when using myLoop hybrid closed-loop at each stage of the pregnancy journey. With the goal of shortening the planning phase, achieving safe pregnancies and deliveries, and caring for healthy mothers for many years to come!
myLoop offers patients
myLoop offers patients in the age of bearing children features specially developed for their needs.
Adaptive and learning
CamAPS FX algorithm adapts insulin delivery based on current and predicted glucose values.
Personal glucose target (PGT)
PGT can be set as low as 4.4 mmol/L, matching the needs of women planning pregnancy or pregnant.
"Boost" and "Ease-off"
Use "Boost" and "Ease-off" modes to respond to unexpected fluctuations in insulin sensitivity.